Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-2 of  2 results for ""Xenograft Model Antitumor Assays""

Your Filters

Geographic : united kingdom
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy.

  • Authors : Reader CS; Centre for Tumour Biology, Barts Cancer Institute, CRUK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, UK.; Vallath S

Subjects: Antigens, Neoplasm/Antigens, Neoplasm/Antigens, Neoplasm/*metabolism ; Carcinoma, Pancreatic Ductal/Carcinoma, Pancreatic Ductal/Carcinoma, Pancreatic Ductal/*metabolism ; Integrins/Integrins/Integrins/*metabolism

  • Source: The Journal of pathology [J Pathol] 2019 Nov; Vol. 249 (3), pp. 332-342. Date of Electronic Publication: 2019 Jul 30.Publisher: John Wiley And Sons Country of Publication: England NLM ID: 0204634 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

A framework for the development of effective anti-metastatic agents.

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Drug Development/Drug Development/Drug Development/*organization & administration ; Neoplasm Metastasis/Neoplasm Metastasis/Neoplasm Metastasis/*drug therapy

  • Source: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2019 Mar; Vol. 16 (3), pp. 185-204.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-2 of  2 results for ""Xenograft Model Antitumor Assays""